23andMe: Collaboration Extension with a New Data Licensing Agreement with GSK

 

Following their five year discovery collaboration, 23andMe and GSK have extended their collaboration by entering into a new non-exclusive data licensing agreement, enabling GSK to utilize the 23andMe database for novel drug target discovery and other research

https://www.globenewswire.com/news-release/2023/10/30/2769169/0/en/23andMe-Announces-Collaboration-Extension-with-a-New-Data-Licensing-Agreement-with-GSK.html